Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin.

نویسندگان

  • R Lassila
  • S Peltonen
  • M Lepäntalo
  • O Saarinen
  • P Kauhanen
  • V Manninen
چکیده

Immunohistochemical studies of human atherosclerotic lesions have demonstrated the occurrence of fibrin deposition and its degradation in the arterial wall. We studied fibrinogen, the generation of thrombin, and the degradation of fibrin in 40 patients with stable peripheral arterial occlusive disease of varying severity, as assessed by the ankle/brachial pressure index and duplex ultrasonography and/or angiography. Circulating fibrinogen (functional and immunological), fibrinopeptide A, thrombin-antithrombin III complex, and D-dimer were measured. The severity of atherosclerosis was associated with both fibrinogen (both functional and immunological) and D-dimer (r = .57, P < .0002, and r = .57, P < .0001, respectively). Fibrinogen and D-dimer showed a significant positive correlation (r = .50, P < .001). Generation of thrombin was detected in 24 patients (60%) by fibrinopeptide A and levels of thrombin-antithrombin III complex. As a sign of coagulation activation and fibrinolysis, we found that thrombin-antithrombin III complex and the degradation of cross-linked fibrin were progressively associated with the extent of vascular disease. The plasmin-mediated fibrin breakdown contributed to increased levels of circulating fibrinogen, an established risk factor for thrombotic complications. The significant correlations between fibrinogen/D-dimer and the severity of atherosclerosis support previous pathological studies and imply that local degradation of cross-linked fibrin is involved in the progression of atherosclerosis.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The effect of plasmin on the subunit structure of human fibrin.

Non-cross-linked, partially cross-linked, and highly crosslinked human fibrin were each digested with plasmin and the changes in the subunit structures of the degradation products were followed sequentially by sodium dodecyl sulfate polyacrylamide gel electrophoresis. The digestion products of non-cross-linked fibrin were similar to those previously reported for fibrinogen. The digestion produc...

متن کامل

بررسی نقش فیبرینوژن در ارتباط احتمالی عفونت هلیکوباکترپیلوری با بیماری‌های ایسکمیک قلبی

     Background & Objective: Epidemiologic studies have shown that infectious agents such as chlamydia pneumonia and helicobacter pylori are linked to ischemic heart disease(IHD). Other studies believe that raised plasma fibrinogen level can be considered as a possible link between H.Pylori infection and IHD. Method: This analytic cross-sectional study was conducted on 261 patients. 131 hospita...

متن کامل

Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.

Samples of normal and atherosclerotic vessels obtained from vascular and cardiothoracic surgery were examined for the distribution of fibrinogen/fibrin I, fibrin II, and fibrin(ogen) degradation products (Fragment D/DD) by using recently characterized monoclonal antibodies that recognize and distinguish the three molecular forms (MAbs 18C6, T2G1, and GC4, respectively) with the ABC-immunoperoxi...

متن کامل

Assessment of the relationship between serum fibrinogen level and chronic Helicobacter pylori infection in patients with or without

 Abstract Background: Infectious agents such as Chlamydia pneumonia or Helicobacter pylori (H. pylori) have been linked to ischemic heart disease (IHD) as the epidemiologic studies have shown. Other studies believed that raised plasma fibrinogen level has been claimed as a possible link between H. pylori infection and IHD. Methods: An analytic cross-sectional study was undertaken on 261 patient...

متن کامل

Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.

The validity of markers in plasma of in vitro thrombolysis was investigated in 12 patients with extensive fibrinogen breakdown (greater than 80%, group 1) and in 12 patients with minimal breakdown (less than 20%, group 2). The patients were treated with 100 mg of recombinant tissue-type plasminogen activator (rt-PA) in the "Thrombolysis in Myocardial Infarction II" (TIMI II) trial. Cross-linked...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Arteriosclerosis and thrombosis : a journal of vascular biology

دوره 13 12  شماره 

صفحات  -

تاریخ انتشار 1993